Aurobindo Pharma Ltd
NSE:AUROPHARMA

Watchlist Manager
Aurobindo Pharma Ltd Logo
Aurobindo Pharma Ltd
NSE:AUROPHARMA
Watchlist
Price: 1 262.45 INR 0.65% Market Closed
Market Cap: 733.2B INR
Have any thoughts about
Aurobindo Pharma Ltd?
Write Note

Aurobindo Pharma Ltd
Investor Relations

Aurobindo Pharma Ltd., founded in 1986 by P.V. Ramprasad Reddy and K. Nityananda Reddy, began its journey in the bustling pharmaceutical landscape of Hyderabad, India. Initially starting as a provider of semi-synthetic penicillin, the company gradually diversified its product portfolio across major therapeutic areas, including cardiovascular, central nervous system, gastrointestinal, and anti-diabetics, among others. With an entrepreneurial vision, Aurobindo leveraged vertical integration to optimize costs and operations—manufacturing everything from raw active pharmaceutical ingredients (APIs) to finished dosage formulations. This strategic approach not only reinforced its cost-leadership position but also enabled the company to meet stringent regulatory requirements in global markets, providing them a competitive edge.

In its quest for expansion, Aurobindo penetrated international markets, including the United States and Europe, through acquisitions and strategic alliances, expanding its manufacturing capabilities and distribution networks. The company generates its revenue primarily through the sale of generic pharmaceuticals, which are manufactured in their state-of-the-art facilities and sold worldwide. Aurobindo's robust research and development (R&D) investments have further fueled its growth by enabling the company to introduce new and complex product lines, including biosimilars and specialty generics. This blend of strategic foresight, operational excellence, and commitment to innovation is what propels Aurobindo Pharma's ongoing narrative in the global pharmaceutical industry.

Show more

Earnings Calls

Show Transcript
Previous
Next
Loading

Management

Mr. Kambam Nithyananda Reddy
Vice Chairman & MD
No Bio Available
Mr. Mettu Madan Mohan Reddy
Whole-Time Director
No Bio Available
Dr. Makkapati Satakarni B.E., M.B.A., Ph.D.
President of Biologics, CEO of Biologics, Vaccines and Peptid & Director
No Bio Available
Mr. Santhanam Subramanian
Chief Financial Officer
No Bio Available
Dr. S. Vijaya Kumar
President of Technical
No Bio Available
Mr. B. Adi Reddy
Compliance Officer & Company Secretary
No Bio Available
Mr. G. P. Prasad
Senior Vice President of Global Finance & Operations
No Bio Available
Dr. Sudhir Bimal Singhi
Head of Global Finance Operations
No Bio Available
Dr. A. Rama Mohana Rao
Chief Quality Officer -Corporate QA
No Bio Available
Dr. V. K. Handa
President of Chemical Research
No Bio Available

Contacts

Address
TELANGANA
Hyderabad
Galaxy, Floor 22-24, Plot No. 1, Survey No. 83/1,, Hyderabad Knowledge City,, Raidurg Panmaktha
Contacts
+914066725000
www.aurobindo.com